Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126746 | SCV000170258 | benign | not specified | 2011-10-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000590572 | SCV000604169 | benign | not provided | 2023-04-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000083698 | SCV000629023 | benign | Familial Mediterranean fever | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590572 | SCV000696049 | likely benign | not provided | 2017-02-01 | criteria provided, single submitter | clinical testing | Variant summary: The MEFV c.1467G>A (p.Gln489Gln) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a benign outcome for this substitution along with 5/5 splice prediction tools predicting the variant not to have a significance impact on normal splicing. The variant was found in 460/121412 control chromosomes (2 homozygotes) at a frequency of 0.0037888, which does not exceed the estimated maximal expected allele frequency of a pathogenic MEFV variant (0.0216506). The variant of interest has not, to our knowledge, been reported in affected individuals via publications; nor evaluated for functional impact by in vivo/vitro studies. In addition, a clinical diagnostic laboratory classified this variant as benign. Taken together, this variant is classified as likely benign. |
Ce |
RCV000590572 | SCV001150751 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | MEFV: BP4, BP7, BS2 |
Illumina Laboratory Services, |
RCV000083698 | SCV001276007 | uncertain significance | Familial Mediterranean fever | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Genome Diagnostics Laboratory, |
RCV002262632 | SCV002543708 | benign | Autoinflammatory syndrome | 2022-02-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390250 | SCV002697482 | likely benign | Inborn genetic diseases | 2022-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Unité médicale des maladies autoinflammatoires, |
RCV000083698 | SCV000115787 | not provided | Familial Mediterranean fever | no assertion provided | not provided | ||
Diagnostic Laboratory, |
RCV000126746 | SCV001740473 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000590572 | SCV001929533 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000083698 | SCV002087403 | likely benign | Familial Mediterranean fever | 2019-12-19 | no assertion criteria provided | clinical testing |